🔓 🔓 🔓 🔓 🔓 🔓 🔓 1,817,260 #SOL (163,859,189 USD) stake unlocked at unknown wallethttps://t.co/BgFusb0QP9 ...

🙋‍♂️ Not setup yet?Here’s how to get involved:Click the link belowPick an active DelegateStake your $ZK and start earning rewards 👇https://t.co/iBroMjdOoA ...

Your $USDT shouldn’t sit idle. 🔥Stake it.Earn $BTC rewards.Up to 600% APR.Here’s how to MEXCmize your gains👇https://t.co/AdhGgUgXCd ...

📌 Not setup yet?Here's how to get involved:▪️Click the link below▪️Pick an active Delegate▪️Stake your $ZK & start earning rewards 👇https://t.co/iBroMjdgz2 ...

This is the right way to "make Ethereum be the home for AI".Don't just do what everyone else would do anyway, just on rails with an octahedron logo instead of a square or circle or pentagon logo. Make something fundamentally better, using meaningful technological improvements in ZK privacy-preserving payments and reputation.Davide Crapis (@DavideCrapis):The internet made access identity-based.Every API call tied to your email, card, or wallet.AI will make it worse.Our proposal:Replace identity with stake.De ...

RT Davide Crapis (@DavideCrapis)The internet made access identity-based.Every API call tied to your email, card, or wallet.AI will make it worse.Our proposal:Replace identity with stake.Deposit once.Make thousands of API calls.Stay unlinkable.Abuse gets slashed.New post with @VitalikButerin 👇 https://t.co/xUAA2cCUtJ ...

It's time to get on board. Help California stake ↓https://t.co/d2aXpdJhIC ...

solana validators down 68% from 2500 to 800. two more quit this month citing per-epoch losses. need $17m stake just to operate now. jpmorgan and state street headlines look great but validators losing money on every block they validate. 750 validators triggers the structural short ...

Core Insights - Bausch Health's valuation indicates potential for recovery, but recent stake reduction by Lombard Odier Asset Management highlights ongoing investor skepticism regarding the company's ability to regain full confidence [1][9]. Company Overview - Bausch Health Companies Inc. is a global healthcare entity with a diverse product portfolio that includes pharmaceuticals, medical devices, and consumer health products, focusing on eye health, gastroenterology, dermatology, and international markets [4][5]. - The company generates revenue through the development, manufacturing, and distribution of both branded and generic drugs, as well as medical devices and consumer health products across various therapeutic segments [5]. Recent Developments - Lombard Odier Asset Management reduced its stake in Bausch Health by 3,334,000 shares in Q3 2025, decreasing its position's value to approximately $11.07 million, which now represents 0.74% of the fund's reportable assets, down from 2.6% in the previous quarter [2][3][6]. - As of November 13, 2025, Bausch Health shares were priced at $6.62, reflecting a 24.6% decline over the past year, significantly underperforming the S&P 500 by 40.08 percentage points [3]. Financial Metrics - Market capitalization of Bausch Health is approximately $2.34 billion, with a trailing twelve months (TTM) revenue of $8.26 billion and a TTM net income of $362 million [3]. Strategic Challenges - The company operates with a mature product portfolio that generates cash but struggles to deliver the necessary growth to support its substantial debt load, raising concerns about its long-term financial flexibility [10]. - Bausch Health's established franchises were not designed to sustain high leverage for extended periods, and the ongoing challenge is whether cash generation can exceed interest costs and legal liabilities [10]. Future Outlook - The company's ability to improve its financial situation hinges on successful refinancing, effective cash conversion, and strategies to reduce leverage without divesting key assets [11].

It's time to get on board.Help Maryland stake ↓https://t.co/iFRtpV37Eq ...